Today: 7 February 2026
Subscribe

Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce, Inc. (NYSE: CRM) heads into the Christmas holiday week with a busy backdrop for investors: fresh product distribution news for its Agentforce platform, a newly announced acquisition aimed at “agentic” marketing, and a market calendar that’s likely to amplify day-to-day volatility simply because liquidity is thinner than usual. As of Sunday, December 21, 2025, the latest available trade data puts Salesforce stock around $259.91, following Friday’s (Dec. 19) close. StockAnalysis For the coming week, CRM stock is less about an earnings catalyst (Salesforce just reported) and more about how investors handicap AI monetization, M&A integration, and macro-driven risk appetite
21 December 2025
····
AppLovin (APP) Stock Week Ahead: Fresh Analyst Targets, Axon AI Momentum, and Key Risks to Watch (Dec. 22–26, 2025)

AppLovin (APP) Stock Week Ahead: Fresh Analyst Targets, Axon AI Momentum, and Key Risks to Watch (Dec. 22–26, 2025)

Date: December 21, 2025 (Sunday) — outlook for the coming trading week AppLovin Corporation (NASDAQ: APP) heads into the Christmas-shortened week with investor attention still locked on the same powerful mix that defined much of 2025: rapid growth, unusually high profitability, and a bullish Wall Street narrative around its AI-driven ad engine (Axon). But with APP trading near prior highs after a huge run, the week ahead is less about scheduled company events and more about liquidity, macro headlines, analyst note flow, and any surprise developments tied to regulation or litigation. Below is a detailed, publication-ready, week-ahead report based on
21 December 2025
·····
Walmart Stock (WMT) Week Ahead: What to Watch After the Nasdaq Switch, CEO Transition, and Holiday-Shortened Trading Week

Walmart Stock (WMT) Week Ahead: What to Watch After the Nasdaq Switch, CEO Transition, and Holiday-Shortened Trading Week

Dec. 21, 2025 — Walmart Inc. (ticker: WMT) heads into the Christmas week trading window with investors balancing upbeat operational momentum against a burst of headline risk from Washington, regulators, and the courts. The stock last traded around $114.36 after Friday’s close, setting the stage for a holiday-shortened week that can amplify moves—up or down—because liquidity and volume are typically thinner. StockAnalysis This week’s backdrop is unusual even by late-December standards: U.S. markets close early on Wednesday (Dec. 24) and are shut on Thursday (Dec. 25), compressing price discovery into fewer hours. Investopedia+2NYSE+2 Meanwhile, Walmart shareholders are digesting a leadership
21 December 2025
···
BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin (BMRN) Stock Jumps on $4.8 Billion Amicus Deal: Latest News, Forecasts and Analyst Outlook for Dec. 21, 2025

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is ending 2025 with a bang. Shares surged on Friday, December 19, closing at $61.15—up 17.71% on the day—after the company announced a $4.8 billion all-cash acquisition of rare-disease peer Amicus Therapeutics. Trading volume spiked to roughly 18.5 million shares, far above BioMarin’s recent daily activity, underscoring how dramatically the market repriced the story in a single session. Investing.com+2Reuters+2 As of Sunday, December 21, 2025, the weekend narrative around BioMarin stock is dominated by that deal—and what it signals: a sharper pivot toward durable rare-disease commercial franchises, an attempt to reduce dependence on BioMarin’s fast-growing
21 December 2025
······
CoreWeave (CRWV) Stock Week Ahead Forecast: DOE Genesis Mission Boost, Citi “Buy/High Risk,” and Holiday-Week Catalysts (Dec. 22–26, 2025)

CoreWeave (CRWV) Stock Week Ahead Forecast: DOE Genesis Mission Boost, Citi “Buy/High Risk,” and Holiday-Week Catalysts (Dec. 22–26, 2025)

Date: Dec. 21, 2025 (Sunday) — U.S. markets reopen Monday after a volatile week for CoreWeave, Inc. (Nasdaq: CRWV). CoreWeave stock is heading into the Christmas-shortened trading week with momentum—and a spotlight that’s only getting brighter. After a sharp selloff that fueled “AI bubble” chatter across Wall Street, CRWV ripped higher on Friday, Dec. 19, closing at $83.00, up $15.32 (+22.64%) in a single session. MarketBeat What triggered the rebound? Two headlines investors are likely to keep trading in the week ahead: Below is a detailed, week-ahead report on the news, forecasts, and key catalysts shaping CoreWeave stock as of
21 December 2025
·····
Intel Stock (INTC) Week Ahead: Nvidia Deal Clearance, US Government Backing, and Holiday-Shortened Trading Risks (Dec. 22–26, 2025)

Intel Stock (INTC) Week Ahead: Nvidia Deal Clearance, US Government Backing, and Holiday-Shortened Trading Risks (Dec. 22–26, 2025)

Intel Corporation stock (NASDAQ: INTC) heads into the week of December 22–26, 2025 with a rare mix of catalysts that are both market-moving and hard to handicap: a newly cleared Nvidia investment, deepening U.S. government involvement, and a Christmas-shortened trading week that can amplify volatility on lighter volume. As of the latest close (Friday, Dec. 19, 2025), Intel shares were around $36.82. MarketBeat Below is what matters most for Intel stock this week, what Wall Street is projecting, and the specific events that could swing sentiment—especially in thin holiday liquidity. Intel stock snapshot heading into Dec. 22 Intel enters the
21 December 2025
····
Eli Lilly Stock Week Ahead (Dec. 22–26, 2025): LLY Enters Holiday Week With Obesity-Drug Catalysts, Pricing Headlines, and Policy Risk

Eli Lilly Stock Week Ahead (Dec. 22–26, 2025): LLY Enters Holiday Week With Obesity-Drug Catalysts, Pricing Headlines, and Policy Risk

As of Sunday, December 21, 2025, Eli Lilly and Company (NYSE: LLY) heads into a holiday-shortened trading week near recent highs, after a busy stretch of headlines spanning next-generation obesity drugs, potentially accelerated FDA review timelines, price cuts aimed at widening access, and a fast-evolving U.S. drug-pricing agenda. The stock’s setup for the week ahead is straightforward: fundamentals and pipeline momentum remain the core bull case, while the key overhangs are pricing pressure, policy uncertainty, and headline-driven volatility typical of a late-December tape. Eli Lilly stock price check: where LLY stands heading into the week LLY last traded around $1,071
21 December 2025
···
CoreWeave Stock (NASDAQ: CRWV): Latest News, Analyst Forecasts, and 2026 Outlook as of December 21, 2025

CoreWeave Stock (NASDAQ: CRWV): Latest News, Analyst Forecasts, and 2026 Outlook as of December 21, 2025

CoreWeave, Inc. (NASDAQ: CRWV) has become one of the most watched—and most debated—AI infrastructure stocks of 2025. As of December 21, 2025 (a Sunday, with U.S. markets closed), CoreWeave shares are sitting near $83, after a sharp late-week rebound that followed weeks of volatility and “AI bubble” hand-wringing across Wall Street. The timing matters: the stock’s latest surge didn’t come from a single earnings print. Instead, it arrived at the intersection of (1) new/renewed bullish coverage from Wall Street, (2) fresh credibility signals from government and NVIDIA, and (3) investor anxiety about leverage, customer concentration, and data-center execution risk—the “boring”
21 December 2025
·····
Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Dec. 21, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) has become one of the market’s more polarizing small-cap defense-tech stories: part autonomous drones, part counter-drone (“counter-UAS”), part ground robotics, and—often forgotten in the headlines—part private industrial wireless networking. December brought a rapid sequence of acquisitions, contract wins, and SEC filings that collectively reshaped the near-term narrative for Ondas Holdings stock heading into 2026. Ondas Holdings Inc.+2Ondas Holdings Inc.+2 As of the most recent close (Friday, Dec. 19, 2025), ONDS finished around $9.22, up roughly 18% on the day, after an unusually heavy session with roughly 125.8 million shares traded—eye-catching volume
21 December 2025
·····
Nike Stock (NKE) Week-Ahead Outlook: Tariffs, China, and Post-Earnings Volatility in Focus (Dec. 22–26, 2025)

Nike Stock (NKE) Week-Ahead Outlook: Tariffs, China, and Post-Earnings Volatility in Focus (Dec. 22–26, 2025)

As of Dec. 21, 2025, Nike, Inc. (NYSE: NKE) enters a holiday-shortened week with investors still digesting a sharp post-earnings selloff—and with a familiar question back at center stage: is the turnaround gaining traction, or simply getting more expensive? Reuters Nike shares closed at $58.71 on Friday (Dec. 19) after dropping roughly 11%, marking a seven-month low and leaving the stock down about 22% year-to-date (per Reuters). Reuters For the coming week (Dec. 22–26), trading conditions will matter as much as headlines. The NYSE will close early at 1:00 p.m. ET on Wednesday, Dec. 24, and will be closed on
21 December 2025
····
Western Digital (WDC) Stock Week Ahead (Dec. 22–26, 2025): Nasdaq-100 Inclusion, Analyst Targets, and What to Watch

Western Digital (WDC) Stock Week Ahead (Dec. 22–26, 2025): Nasdaq-100 Inclusion, Analyst Targets, and What to Watch

Dateline: December 21, 2025 (Sunday) Western Digital Corporation (NASDAQ: WDC) heads into the week with a rare combination of index-driven demand and fundamental momentum. The headline catalyst is Western Digital’s addition to the Nasdaq-100, effective before the market opens Monday, December 22, 2025—a change that can trigger mechanical buying from passive funds and raise trading volume. Reuters+1 But this is also a holiday-shortened week, with U.S. stock markets scheduled for an early close on Wednesday, Dec. 24 (1:00 p.m. ET) and closed on Thursday, Dec. 25. Thin liquidity can magnify price moves—up or down—especially around major index events. Nasdaq+1 Below
21 December 2025
·····
Applied Materials (AMAT) Stock Week Ahead: Holiday-Shortened Trading, AI Equipment Demand Signals, and China Export-Curb Crosswinds (Dec 22–26, 2025)

Applied Materials (AMAT) Stock Week Ahead: Holiday-Shortened Trading, AI Equipment Demand Signals, and China Export-Curb Crosswinds (Dec 22–26, 2025)

Dec. 21, 2025 — Applied Materials, Inc. (NASDAQ: AMAT) heads into a holiday-shortened trading week with its stock near recent highs, investors focused on two big, competing forces: AI-driven wafer-fab equipment demand and ongoing U.S.-China export-control uncertainty. AMAT last traded around $256.41 (latest available close/prints from Friday), setting the stage for a week where liquidity will be thin, macro headlines could punch above their usual weight, and semiconductor-equipment names may trade more on sentiment than on company-specific catalysts. Nasdaq Below is a week-ahead briefing—what’s new as of 21.12.2025, what analysts are saying, and the most important levels and catalysts to
21 December 2025
····
1 … 1,347 1,348 1,349 1,350 1,351 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop